CBD improves cognition in Alzheimer’s model

Latest articles

The Alliance for Longevity Initiatives – fighting aging

Advancing legislation and policies that aim to increase healthy human lifespan. Longevity is a journey that would be good to imagine we're all taking together;...

Team builds first living robots – that can reproduce

AI-designed Xenobots reveal entirely new form of biological self-replication which could prove promising for regenerative medicine. Birds do it, bees do it... now even living...

Aging in place trailblazer focus – Carewell

Carewell – aiding individuals through their caregiving journey with empathy and knowledge. Over the coming weeks, we will be bringing you extracts from 7 trailblazer...

Humanpeople raising £700k for AI preventative health platform

Digital preventative health platform combines blood, DNA and microbiome testing to power up your healthspan with highly personalised supplements. DISCLOSURE: Longevity.Technology (a brand of...

Most read

New supplement slows aging and promotes weight loss

Sugar-proof your way to a longer life. Reducing AGEs to slow aging and increase weight loss – how one supplement is fighting the war...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Resveratrol – the small molecule with big antiaging ideas

When it comes to antiaging molecules, we can learn a thing or two from plants. As so often in natural world, plants have a few...

Editor's picks

The Alliance for Longevity Initiatives – fighting aging

Advancing legislation and policies that aim to increase healthy human lifespan. Longevity is a journey that would be good to imagine we're all taking together;...

Team builds first living robots – that can reproduce

AI-designed Xenobots reveal entirely new form of biological self-replication which could prove promising for regenerative medicine. Birds do it, bees do it... now even living...

Aging in place trailblazer focus – Carewell

Carewell – aiding individuals through their caregiving journey with empathy and knowledge. Over the coming weeks, we will be bringing you extracts from 7 trailblazer...

Click the globe for translations.

High doses of cannabidiol restores protein function to reduce beta-amyloid plaques in Alzheimer’s.

Alzheimer’s disease is a neurodegenerative disease that causes beta-amyloid plaques to build up in the brain, a key distinction for those who suffer from this type of dementia. An experimental model of early onset familial Alzheimer’s by the Dental College of Georgia at Augusta University demonstrates that a two-week course of high doses of CBD (cannabidiol, which is derived directly from the hemp or cannabis plant), can restore the function and levels of two crucial plaque-removing proteins, TREM2 and IL-33.

Longevity.Technology: CBD oil is wearing two hats at the moment, being hailed as an investigative new drug by some, while still a regular and beneficial supplement for others. The FDA urges caution, making it clear that it has “seen only limited data about CBD safety [1]“, but its ability to address some of the key brain pathways mean that further research, both in terms of CBD’s potential and ensuring its safety are needed. There is a very real need to improve outcomes for Alzheimer’s sufferers, and this study, albeit murine, is cause for cautious optimism.

The study found that CBD appears to normalise levels of IL-33; this protein is mostly expressed in the brain, where it signals the presences of invaders, such as beta amyloid build-up. In addition, research points to IL-33 having a regulatory role as well [2], as it can dial immune response either up or down as the environment dictates. In Alzheimer’s, that means it can turn down inflammation and help restore balance to the immune system.

The research team felt that IL-33’s up and down expression could warrant IL-33’s consideration as both a clear biomarker and a treatment target for disease [3].

Proteins TREM2 and IL-33 play a key role in the continual housekeeping that occurs in the brain; microglial cells engulf dead cells and beta amyloid in a process called phagocytosis.

 


 

Alzheimer’s sufferers can experience movement problems such as shuffling, stiffness, drifting to the side or an impaired gait; mice with Alzheimer’s run in an endless tight circles, but this behaviour was arrested when the mice were treated with CBD.

 


 

Beta amyloid is produced in the brain when amyloid-beta precursor proteins degrade. Amyloid-beta precursor proteins are concentrated in the synapses of neurons, functioning as cell surface receptors and playing a part in synapse formation and neural plasticity. As they degrade, the microglial cells should clear these by-products away, but if this process doesn’t happen, in part due to a lack of key ‘helper’ proteins TREM2 and IL-33, the beta amyloid forms clumps of plaque, which cause toxic damage to nerve cells and interrupt normal brain function.

By restoring the function and levels of these proteins, cognition and function in the mice model was shown to improve in the study. Brain function in the mice was assessed by methods like the ability to differentiate between familiar and new items and the rodents’ movement. The study found that CBD treatment effectively increased IL-33 levels sevenfold, and TREM2 tenfold [4].

Alzheimer’s sufferers can experience movement problems such as shuffling, stiffness, drifting to the side or an impaired gait; mice with Alzheimer’s run in an endless tight circles, but this behaviour was arrested when the mice were treated with CBD.

CBD also reduce levels of the immune protein IL-6, which is associated with the high inflammation levels found in Alzheimer’s disease.

“Right now we have two classes of drugs to treat Alzheimer’s,” says Dr John Morgan, neurologist and director of the Movement and Memory Disorder Programs in the MCG Department of Neurology and study co-author. “One class increases levels of the neurotransmitter acetylcholine, which also are decreased in Alzheimer’s, and another works through the NMDA receptors involved in communication between neurons and important to memory. But we have nothing that gets to the pathophysiology of the disease [3].”

Familial Alzheimer’s is an inherited version of the disease; symptoms typically manifest in the patient’s 30s or 40s and it accounts for about 10-15% of patients, and like the more typical late-onset Alzheimer’s, the familial version is incurable [5].

The researchers hope CBD should be at least equally effective in the more common version of Alzheimer’s, and are already are planning a model for this, with a view to moving towards establishing a clinical trial.

[1] https://bit.ly/3lSVeUK
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255965/
[3] https://jagwire.augusta.edu/cbd-reduces-plaque-improves-cognition-in-model-of-familial-alzheimers/
[4] https://content.iospress.com/articles/journal-of-alzheimers-disease/jad210026
[5] https://www.alzforum.org/early-onset-familial-ad/overview/what-early-onset-familial-alzheimer-disease-efad

Image credit: The Dental College of Georgia, left to right; Babak Baban, John Morgan and Hasan Khodadadi
Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.

Most popular

New supplement slows aging and promotes weight loss

Sugar-proof your way to a longer life. Reducing AGEs to slow aging and increase weight loss – how one supplement is fighting the war...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Resveratrol – the small molecule with big antiaging ideas

When it comes to antiaging molecules, we can learn a thing or two from plants. As so often in natural world, plants have a few...

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

Related articles

Printers that can now print DNA

DNA Script obtains CE Mark for SYNTAX DNA printing platform. DNA Script, a leader in Enzymatic DNA Synthesis (EDS), announced the CE marking of its SYNTAX System, the...

Eliminating senescent cells in fat can alleviate signs of diabetes

Deleting dysfunctional cells could lead to game-changing treatments for diabetes and other metabolic diseases. Eliminating old, dysfunctional cells in human fat also alleviates signs of...

Longevica: bridging the gap between longevity science and consumers

Longevica CEO sheds further light on work to develop an “open research platform” to drive both longevity science and commercialisation. Following yesterday’s $2.5 million funding...

Young blood: discover the possibilities of plasma based therapy

The evolution of plasma-based therapeutics is accelerating – our FREE report cuts through the young blood hype for the lowdown on the latest therapies. Our...

Longevica raises $2.5 million for open research platform

$2.5m in funding to support longevity research platform and study to accelerate the discovery of life extension mechanisms, launching in 2022. Longevica, a life science...

    Subscribe to our newsletter